Rapid Therapeutic Science Laboratories

(OTC) RTSL

Current Price$0.01

Market Cap$53,000

Since IPO (2014)-100%

5 Year-100%

1 Year-19%

1 Month+0%

Rapid Therapeutic Science Laboratories Financials at a Glance

Market Cap

$53,000

Revenue (TTM)

$0.00

Net Income (TTM)

$634.51K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.06 (Low)

Dividend

$0.00

Beta (Volatility)

-0.06 (Low)

Price

$0.01

Volume

Open

$0.01

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

Dividend

$0.00

Beta (Volatility)

-0.06 (Low)

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

RTSL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rapid Therapeutic Science Laboratories

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Donal R. Schmidt, Jr., MBA

Headquarters

Dallas, TX 75201, US

RTSL Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-19%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$53.00K

Shares Outstanding

8.83M

Volume

Avg. Volume

0.333

Financials (TTM)

Gross Profit

$23.97K

Operating Income

$83.23K

EBITDA

$59.25K

Operating Cash Flow

$1.15M

Capital Expenditure

$39.16K

Free Cash Flow

$1.19M

Cash & ST Invst.

$0.00

Total Debt

$3.45M

Rapid Therapeutic Science Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$5.99K

N/A

Gross Margin

0.00%

N/A

Market Cap

$53.00K

N/A

Market Cap/Employee

$17.67K

N/A

Employees

N/A

Net Income

$34.54K

+94.0%

EBITDA

$3.39K

+99.0%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$3.45M

+8.9%

Accounts Receivable

$0.00

N/A

Inventory

$175.05K

+0.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$3.45M

+4.0%

Return on Assets

-18.94%

N/A

Return on Invested Capital

2.70%

N/A

Free Cash Flow

$7.33K

+97.1%

Operating Cash Flow

$7.33K

+97.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CTBOCantabio Pharmaceuticals, Inc.

CTBOCantabio Pharmaceuticals, Inc.$1.01+0.00%

DGCRFDiagnocure, Inc.

DGCRFDiagnocure, Inc.$0.00+0.00%

QSAMQSAM Biosciences, Inc.

QSAMQSAM Biosciences, Inc.$8.30-99.95%

NWYUNew You, Inc.

NWYUNew You, Inc.$0.00+0.00%

NNMXNanomix Corporation

NNMXNanomix Corporation$0.00+0.00%

NMMCFNMC Health plc

NMMCFNMC Health plc$0.00+0.00%

CBDHFHempfusion Wellness Inc.

CBDHFHempfusion Wellness Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

AAPLApple

AAPLApple$280.14+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About RTSL

What is the current price of Rapid Therapeutic Science Laboratories?

Rapid Therapeutic Science Laboratories is trading at $0.01 per share.

What is the 52-week range for Rapid Therapeutic Science Laboratories?

Over the past 52 weeks, Rapid Therapeutic Science Laboratories has traded between $0.00 and $0.01.

How much debt does Rapid Therapeutic Science Laboratories have?

As of the most recent reporting period, Rapid Therapeutic Science Laboratories reported total debt of $3.45M.

How much cash does Rapid Therapeutic Science Laboratories have on hand?

Rapid Therapeutic Science Laboratories reported N/A in cash and cash equivalents in its most recent financial results.

What is Rapid Therapeutic Science Laboratories’s dividend yield?

Rapid Therapeutic Science Laboratories does not currently have a dividend yield.

Rapid Therapeutic Science Laboratories

Rapid Therapeutic Science Laboratories Financials at a Glance

RTSL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Rapid Therapeutic Science Laboratories

RTSL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Rapid Therapeutic Science Laboratories Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RTSL

What is the current price of Rapid Therapeutic Science Laboratories?

What is the 52-week range for Rapid Therapeutic Science Laboratories?

How much debt does Rapid Therapeutic Science Laboratories have?

How much cash does Rapid Therapeutic Science Laboratories have on hand?

What is Rapid Therapeutic Science Laboratories’s dividend yield?

Premium Investing Services